Financial reports
10-Q
2024 Q1
Quarterly report
14 Feb 24
ARS
2023 FY
Annual report to shareholders
26 Jan 24
10-K
2023 FY
Annual report
29 Dec 23
10-Q
2023 Q3
Quarterly report
14 Aug 23
10-Q
2023 Q2
Quarterly report
12 May 23
10-Q
2023 Q1
Quarterly report
10 Feb 23
10-K
2022 FY
Annual report
22 Dec 22
10-Q
2022 Q3
Quarterly report
11 Aug 22
10-Q
2022 Q2
Quarterly report
12 May 22
10-Q
2022 Q1
Quarterly report
10 Feb 22
Current reports
8-K
Other Events
5 Apr 24
8-K
Other Events
18 Mar 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
13 Mar 24
8-K
Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2024 Financial Results and Provides Business Update
15 Feb 24
8-K
Other Events
14 Feb 24
8-K
Citius Pharmaceuticals Announces Nomination of Pharmaceutical Executive Robert J. Smith to its Board of Directors
23 Jan 24
8-K
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
5 Jan 24
8-K
Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2023 Financial Results and Provides Business Update
2 Jan 24
8-K
Citius Pharmaceuticals Executes Definitive Agreement to
24 Oct 23
8-K
Other Events
25 Sep 23
Registration and prospectus
S-3
Shelf registration
23 Feb 24
S-8
Registration of securities for employees
23 Feb 24
425
Business combination disclosure
24 Oct 23
424B5
Prospectus supplement for primary offering
5 May 23
S-8
Registration of securities for employees
10 Feb 23
25-NSE
Exchange delisting
8 Aug 22
424B4
Prospectus supplement with pricing info
23 Jul 21
POS AM
Prospectus update (post-effective amendment)
2 Jul 21
S-8
Registration of securities for employees
22 Jun 21
424B3
Prospectus supplement
20 May 21
Proxies
DEFA14A
Additional proxy soliciting materials
26 Jan 24
DEF 14A
Definitive proxy
26 Jan 24
DEFA14A
Additional proxy soliciting materials
22 Dec 22
DEF 14A
Definitive proxy
22 Dec 22
DEFA14A
Additional proxy soliciting materials
20 Dec 21
DEF 14A
Definitive proxy
20 Dec 21
DEFA14A
Additional proxy soliciting materials
28 May 21
DEFA14A
Additional proxy soliciting materials
12 Apr 21
DEF 14A
Definitive proxy
12 Apr 21
PRE 14A
Preliminary proxy
12 Mar 21
Other
EFFECT
Notice of effectiveness
4 Mar 24
EFFECT
Notice of effectiveness
9 Jul 21
EFFECT
Notice of effectiveness
21 May 21
CORRESP
Correspondence with SEC
19 May 21
UPLOAD
Letter from SEC
18 May 21
EFFECT
Notice of effectiveness
19 Apr 21
CORRESP
Correspondence with SEC
12 Apr 21
UPLOAD
Letter from SEC
9 Apr 21
SEC STAFF
SEC staff action: Order
12 Mar 21
SEC STAFF
SEC staff action: Order
11 Feb 21
Ownership